Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

ClinicalTrials.gov ID: NCT03520127

Public ClinicalTrials.gov record NCT03520127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this registry study is to collect use and clinical outcomes data following breast lesion excision or sampling with the Intact BLES.

Study identification

NCT ID
NCT03520127
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Medtronic Surgical Technologies
Industry
Enrollment
176 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2017 (Actual)
Primary completion
Feb 15, 2019 (Actual)
Completion
Feb 28, 2019 (Actual)
Last update posted
May 16, 2019

2017 – 2019

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Birmingham Breast Care Birmingham Alabama 35205 —
Winship Cancer Institute-Emory St. Joseph's Atlanta Georgia 30342 —
Dalton Surgical Group Dalton Georgia 30720 —
Metro Surgical Associates Inc. Lithonia Georgia 30058 —
Holyoke Medical Center Holyoke Massachusetts 01040 —
Nashville Breast Center Nashville Tennessee 37203 —
The Breast Center at Chesapeake Regional Healthcare Chesapeake Virginia 23320 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03520127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2019 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03520127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →